Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Pathology

• Publication date

  2013-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ajpath.2013.04.002PMID 23665200
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.

  2012cited by this paper
• Tumor gangliosides and T cells: a deadly encounter.

  2012cited by this paper
• Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy

  2012cited by this paper
• A current viewpoint of lymphangioleiomyomatosis supporting immunotherapeutic treatment options.

  2012cited by this paper
• Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer.

  2012cited by this paper
• Differentially regulated expression of 9-O-acetyl GD3 (CD60b) and 7-O-acetyl-GD3 (CD60c) during differentiation and maturation of human T and B lymphocytes.

  2011cited by this paper
• The idiotype (Id) cascade in mice elicited the production of anti‐R24 Id and anti‐anti‐Id monoclonal antibodies with antitumor and protective activity against human melanoma

  2011cited by this paper
• Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

  2011cited by this paper
• Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen.

  2011cited by this paper
• Ganglioside GD3 Enhances Adhesion Signals and Augments Malignant Properties of Melanoma Cells by Recruiting Integrins to Glycolipid-enriched Microdomains*

  2010cited by this paper
• GD3 Accumulation in Cell Surface Lipid Rafts Prior to Mitochondrial Targeting Contributes to Amyloid-β-induced Apoptosis

  2010cited by this paper
• Characterization of GD3 ganglioside as a novel biomarker of mouse neural stem cells.

  2010cited by this paper
• Melanoma-associated antigen expression in lymphangioleiomyomatosis renders tumor cells susceptible to cytotoxic T cells.

  2009cited by this paper
• GD3, an overexpressed tumor-derived ganglioside, mediates the apoptosis of activated but not resting T cells.

  2009cited by this paper
• Feasibility of immunotherapy for lymphangioleiomyomatosis.

  2009cited by this paper
• Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

  2008cited by this paper
• The role of NKT cells in tumor immunity.

  2008cited by this paper
• Symptom and quality of life results of an international randomised phase III study of adjuvant vaccination with Bec2/BCG in responding patients with limited disease small-cell lung cancer.

  2008cited by this paper
• Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T‐cell ligand

  2008cited by this paper
• Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

  2008cited by this paper
• Role of the Mitogen-Activated Protein Kinase Signaling Pathway in the Regulation of Human Melanocytic Antigen Expression

  2006cited by this paper
• MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development

  2005cited by this paper
• Milk‐Derived GM3 and GD3 Differentially Inhibit Dendritic Cell Maturation and Effector Functionalities

  2005cited by this paper
• Ganglioside GD3 shedding by human gliomas

  2005cited by this paper
• Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).

  2005cited by this paper
• A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma.

  2005cited by this paper
• Tumor Regression and Autoimmunity in Patients Treated With Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Interleukin 2: A Phase I/II Study

  2005cited by this paper
• Survival and disease progression in UK patients with lymphangioleiomyomatosis

  2004cited by this paper
• Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR.

  2003cited by this paper
• Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody.

  2003cited by this paper
• Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation

  2002cited by this paper
• The spectrum of mutations in TSC1 and TSC2 in women with tuberous sclerosis and lymphangiomyomatosis.

  2001cited by this paper
• Down‐Regulation of GD3 Ganglioside and Its O‐Acetylated Derivative by Stable Transfection with Antisense V

  2000cited by this paper
• Lymphangioleiomyomatosis: clinical features, management and basic mechanisms

  1999cited by this paper
• Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

  1999cited by this paper
• Mapping effector functions of a monoclonal antibody to GD3 by characterization of a mouse-human chimeric antibody

  1994cited by this paper
• Transbronchial Biopsy in Lymphangiomyomatosis of the Lung HMB45 for Diagnosis

  1993cited by this paper
• Progression of human cutaneous melanoma is associated with loss of expression of c‐kit proto‐oncogene receptor

  1992cited by this paper
• Treatment with high dose mouse monoclonal (anti‐GD3) antibody R24 in patients with metastatic melanoma

  1992cited by this paper
• ME491 melanoma-associated glycoprotein family: antigenic identity of ME491, NKI/C-3, neuroglandular antigen (NGA), and CD63 proteins.

  1992cited by this paper
• Humoral immune response in disease-free advanced melanoma patients after vaccination with melanoma-associated gangliosides. EORTC Cooperative Melanoma Group.

  1991cited by this paper
• Humoral immune response in disease‐free advanced melanoma patients after vaccination with melanoma‐associated gangliosides

  1991cited by this paper

• The development for emerging biomarkers of lymphangioleiomyomatosis

  2024cites this paper
• Dysregulated lipid metabolism in lymphangioleiomyomatosis pathogenesis as a paradigm of chronic lung diseases

  2023cites this paper
• Benign tumors in TSC are amenable to treatment by GD3 CAR T cells in mice

  2021influential citation
• Human Pluripotent Stem Cell Modeling of Tuberous Sclerosis Complex Reveals Lineage-Specific Therapeutic Vulnerabilities

  2020cites this paper
• 1 TSC 2-deficiency potentiates a catabolic signaling switch that differentiates neural and neural crest lineage development and progressive disease manifestations

  2019cites this paper
• Immunotherapy for Lymphangioleiomyomatosis and Tuberous Sclerosis: Progress and Future Directions.

  2019cites this paper
• Stem cell models identify lineage-specific catabolic signaling, neoplastic mechanisms and therapeutic vulnerabilities in tuberous sclerosis

  2019cites this paper
• Ganglioside GD3 synthase (GD3S), a novel cancer drug target

  2018cites this paper
• Immune Checkpoint Ligand PD‐L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis

  2018cites this paper
• Could Immunotherapy Sink Its Teeth into Lymphangioleiomyomatosis?

  2018cites this paper
• Vitamin D binding protein: a new biomarker of disease severity in lymphangioleiomyomatosis

  2018cites this paper
• Human Pluripotent Stem Cell-Derived TSC2-Haploinsufficient Smooth Muscle Cells Recapitulate Features of Lymphangioleiomyomatosis.

  2017cites this paper
• Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice

  2016cites this paper
• Dysregulated Expression of Glycolipids in Tumor Cells: From Negative Modulator of Anti-tumor Immunity to Promising Targets for Developing Therapeutic Agents

  2016cites this paper
• Diagnosis value of membrane glycolipids biochemistry index in intracranial and gastrointestinal tumors.

  2015cites this paper
• Plasma Content Variation and Correlation of Plasmalogen and GIS, TC, and TPL in Gastric Carcinoma Patients: A Comparative Study

  2015cites this paper
• The neural crest lineage as a driver of disease heterogeneity in Tuberous Sclerosis Complex and Lymphangioleiomyomatosis

  2014cites this paper